second testimonial

“I’ve been able to grow BIOVECTRA and it has been wonderful for me.”

Bruna Coutinho
Principal Scientist, Process Development – Biologics

Bruna Coutinho has experienced many adventures on her path pursuing a career in science. Her most recent journey was joining BIOVECTRA, finding a new home in Prince Edward Island and starting her family. Originally from Brazil, Bruna studied microbiology and immunology there, got her Biotechnology Ph.D. in Italy, and completed post-doctoral work in Seattle. Bruna’s pride in her team, commitment to problem solving, and pursuit of biotechnology is infectious – in the best way possible! Bruna thrives on challenges, performing her best, and encouraging others. She sets her sights on a career with industry because of her strong desire to do something tangible and productive with her knowledge. Bruna joined the company as a Research Scientist and was quickly promoted to Senior Scientist and then to lead of the Process Development Biologics team. She and her team work to help clients solve their early-stage problems in the lab and support them to scale-up their products to be ready for manufacturing. The collaborative and helpful nature of her team, new challenges to solve in the lab, and ongoing learning feeds Bruna’s professional growth and passion for her work.

Oliver Technow - Chief Executive Officer

  • Industry Master Degree from Frankfurt Chamber of Commerce, Frankfurt Germany.
  • More than 20 years of global pharmaceutical industry experience.
  • Held numerous leadership positions in commercial development, marketing and brand management, and lifecycle management and has extensive product launch and market access expertise in Europe and North America.
  • In 1997, joined Eisai GmbH in Frankfurt, Germany and in 2002, was appointed Director, CNS Business Unit; in 2006, was appointed Vice President, Head of Global Marketing for Eisai Inc. in Woodcliff Lake, NJ;  in 2011, was appointed Vice President, Established Products Business Unit; in 2013, was appointed President & General Manager for Eisai Limited in Mississauga, ON.
  • Appointed President of BIOVECTRA Inc., December 10, 2015.
  • Board Director for BIOTECanada
  • Member of the Steering Council of Innovative Medicines Canada (IMC)
  • In 2017, appointed to the Government of Canada’s Health/Bio-sciences Strategic Economic Table
  • In November 2019, promoted to Chief Executive Officer at BIOVECTRA
  • In June 2020, named new Chair of PEI BioAlliance Board of Directors